Compare INBS & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INBS | ORIS |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 4.6M |
| IPO Year | N/A | 2024 |
| Metric | INBS | ORIS |
|---|---|---|
| Price | $0.55 | $0.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 148.5K | ★ 2.1M |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $3,292,042.00 | ★ $12,317,000.00 |
| Revenue This Year | $778.48 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $510.25 |
| Revenue Growth | ★ 3.26 | N/A |
| 52 Week Low | $0.56 | $0.08 |
| 52 Week High | $2.75 | $2.85 |
| Indicator | INBS | ORIS |
|---|---|---|
| Relative Strength Index (RSI) | 28.68 | 39.78 |
| Support Level | $0.68 | $0.11 |
| Resistance Level | $0.73 | $0.13 |
| Average True Range (ATR) | 0.05 | 0.01 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 5.41 | 16.02 |
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).